Recently, we have shown that type-1 IFNs play a major role in the pathogenesis of periodontal disease by disrupting innate immunological functions, constitutively priming CD4+ T-cells by DCs leading to elevated RANKL expression and, subsequently, alveolar bone loss (5). Here, TNFSF11 is linked to periodontal disorder.